Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies. A new approach using AI and stem cell models could finally shift the balance. By Tom Cassauwers Belgian AI company Kantify was doing business as usual until a cancer diagnosis forced the team to rethink their direction. “We built algorithms … Read more

The post AI joins the quest to find new treatments for rare diseases appeared first on Horizon Magazine Blog.